Acute myeloid leukemia (AML) is a heterogeneous blood-borne malignancy with an total 5-year survival price of 25 % . Regardless of substantial genetic...
Picture
Picture courtesy of Erge Edgu-Fry
As a rising high-school freshman,14-year-old Arda Edgu-Fry seems to be ahead to many issues this faculty yr – assembly...
Moleculin Biotech has accomplished an end-of-phase 2 assembly with the FDA concerning the investigation of annamycin (MB-106) together with cytarabine for the remedy...
